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Evaluation of dose-related genotoxicity of desflurane by SCE
human lymphocytes
Bahar AYDINLI1, Ayşegül ÖZGÖK1, Zeliha Aslı DEMİR1, Seyhan YAĞAR1, Mehmet Ali ERGÜN2,
Derya KARAER2, Mustafa Necmi İLHAN3

Aim: To evaluate dose-related genotoxicity of desflurane. In the literature, there are studies with equivocal data regarding
the potential genotoxicity of inhalational anesthetics. However, it is important to know about the genotoxic safety of an
anesthetic agent.
Materials and methods: Two groups were enrolled into the study. The first group was maintained with a desflurane
minimum alveolar concentration (MAC) of 0.5 and the second was maintained with 1 MAC of desflurane. Blood
samples were obtained and studied at the baseline and after 3 h of anesthesia via sister chromatid exchange (SCE) assay.
Results: In both groups, SCEs per cell were noted to increase after 3 h of anesthesia, though the increase was only
significant in the 1 MAC group.
Conclusion: There are limited data on the genotoxicity of desflurane. It seems that 1 MAC of desflurane has a genotoxic
effect, as shown by SCE assay.
Key words: Anesthesiology, desflurane, SCE

Desfluran genotoksisitesinin insan lenfositlerinde SCE ile değerlendirilmesi
Amaç: İnhalasyon anesteziklerinin potansiyel genotoksisitesi literatürde farklı sonuçları bulunan ve çalışmaları halen
devam eden bir konudur. Yaygın kullanılan inhalasyon ajanlarının genotoksik güvenliğini belirlemek hastalarda ajan
seçiminde önemlidir.
Yöntem ve gereç: Bu çalışma desfluranın doza bağlı genotoksisitesini araştırmak amacıyla planlandı. Çalışmaya 2 grup
dahil edildi, 1 grup 0,5 MAC, diğer grup 1 MAC desfluran ile idame edildi. Bazal ve anestezinin 3. saatindeki kan
örnekleri SCE assay test ile çalışıldı.
Bulgular: Her iki grupta da bazal SCE oranı anestezinin 3. saatinde artmış olarak bulundu. Fakat 1 MAC grubundaki
bazale göre anestezinin 3. saatindeki artış istatistiksel olarak anlamlıydı.
Sonuç: Desfluranın genotoksisitesiyle ilgili sınırlı bilgi mevcuttur. SCE frekanslarını çalışarak 1 MAC desfluranın
genotoksik etkilerini belirledik.
Anahtar sözcükler: Anestezi, desfluran, SCE
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Introduction
Inhalation anesthetics are volatile substances and
are found at the liquid state at room temperature. The
induction rates of these anesthetics differ according
to their anesthetic, analgesic, and muscle relaxation
effects. The strengths of inhalation anesthetics
are determined by their minimum alveolar
concentrations (MAC). MAC is determined by the
minimal alveolar drug dose that is required to prevent
the reflex formation against a painful stimulant like
skin incisions in 50% of the subjects. The individual
MAC rates differ between 0.5 and 1.5 MAC (1).
The mutagenic effects of anesthetic gases have been
studied (2,3). Both experimental and epidemiologic
studies demonstrated that not only the patients but
also the operation staff exposed to anesthetic gases
are at risk (4,5). Cobett et al. demonstrated fetal
mortality in rats exposed to low doses of nitrous oxide
during pregnancy (6). Nitrogen protoxide may affect
DNA synthesis by inhibiting methionine synthase.
Negative effects on reproductive functions have also
been demonstrated. Epidemiologic studies indicated
that exposure to nitrogen protoxide at lower doses
and at longer periods increased the spontaneous
abortion rate (7).
Sardas et al. showed the genotoxic effect of
isoflurane in human lymphocytes (8). Lüleci et
al. indicated the reversible mutagenic effect of
sevoflurane in human lymphocytes (9). Desflurane
is a halogenated methyl ether, soluble in blood and
other tissues. The structure and pharmacodynamics
of desflurane is similar to that of isoflurane (10).
Regarding the medical literature, there are few
studies demonstrating the dose-dependent genotoxic
effect of desflurane. We therefore aimed to study the
potential genotoxic effect of desflurane at 2 different
doses, 0.5 and 1 MAC.
Materials and methods
After the obtaining of informed and written
consent, 30 patients of physical status I-II according
to the American Society of Anesthesia (ASA), who
underwent gastroenterological and urological major
surgery, were enrolled in the study. The study was
approved by the hospital ethics committee. All
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patients were randomized into 2 groups with 15
patients in each group: Group 1, 0.5 MAC (desflurane
3%), and Group 2, 1 MAC (desflurane 6%). Patients
with diabetes mellitus, alcohol abuse, and cigarette
usage were excluded. Patients received 0.07 mg kg–1
of midazolam intramuscularly as premedication
30 min prior to anesthesia induction. Noninvasive
blood pressure, ECG, oxygen saturation by a pulse
oximeter, end-tidal anesthetic agent, and end-tidal
CO2 (Capnomac Ultima, Datex, Helsinki, Finland)
were used for routine patient monitoring in the
operating room. After insertion of a peripheral
venous catheter, 3 mL of blood was withdrawn into a
heparinized syringe for the sister chromatid exchange
(SCE) assay test. Genotoxicity was determined via
SCE assay because of its low cost and availability.
The comet assay, mitotic index, and chromosome
aberration techniques are other alternative methods
that could be used for this purpose (5,8). Anesthesia
was induced with 1 μg kg–1 fentanyl, 3-7 mg kg–1
thiopental sodium, and 0.5-0.6 mg kg–1 rocuronium
bromide. Anesthesia was maintained with 0.5 MAC
(Group 1) or 1 MAC (Group 2) desflurane in an O2/
air mixture. N2O was not used in any of the patients,
but fentanyl was added for pain relief if required. As
midazolam, thiopental, and fentanyl have relative
genotoxicity but are safer than other anesthetics, we
preferred these as standard medications (11,12).
Sister chromatid exchange assay test
Peripheral blood samples (3 mL) of the patients
were also taken into heparinized tubes 180 min after
the initiation of anesthesia. Blood samples were
cultured at 37 °C for 72 h in RPMI-1640 medium
(Biological Industries, Israel) supplemented with
1.5% phytohemagglutinin (Biological Industries),
20% fetal calf serum (Biological Industries,), 200 mM
l-glutamine (Biological Industries), and antibiotics.
At 24 h, 25 μM 5-bromodeoxyuridine (SERVA,
Germany) was added to the culture. All cultures were
incubated in the dark at 37 °C for 72 h. During the last
hour of incubation, colcemid (Biological Industries)
at a final concentration of 0.1 μg mL–1 was added to
all cultures to arrest the dividing of lymphocytes in
mitosis. After hypotonic treatment in 0.075 M KCl
solution for 20 min at 37 °C, chromosomes were fixed
in methanol and acetic acid (3:1 v/v). The fixed cells
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were dropped onto clean microscope slides, which
were treated as follows: the slides were immersed into
Hoechst 33258 solution for 25 min in the dark and
washed with phosphate-buffered saline (PBS). They
were then placed in a glass tray containing PBS, 10
cm away from a UV source for 120 min, and cleaned
with distilled water. The slides were stained with 2%
Giemsa for 15 min (13-15). The samples were spread
on glass slides and analyzed with a light microscope
to determine the SCE frequency.
Statistical analysis
All results were expressed as mean ± standard
error of mean (SEM). Because of the abnormal
distribution, nonparametric statistics were utilized.
Two independent groups were compared with the
Mann-Whitney U test. (SPSS 10.0.1 for Windows)
and P < 0.05 was considered statistically significant.
The distribution of data is shown in box plot graphics
in Figure 1.

Discussion
Anesthetic gases have genotoxic effects and
also have negative effects on both the patients and
the operation staff (16). As the genotoxic effects of
anesthetic gases have been reported to begin at 1 h
and peak after 2 h, the blood samples were drawn
at 3 h after exposure to anesthetic gases in the
current study (9,11). The SCE frequencies in Group
1 were noted to increase between the preoperative
and intraoperative 3-h period, though it was not
statistically significant (P = 0.117). SCE frequencies
of Group 2 in the same period yielded a statistically
14
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Results
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Regarding the 30 patients, 19 of them were male
(63.3%) and 11 of them were female (36.7%). The
mean ages for Groups 1 and 2 were 45.26 ± 11.69
and 41.06 ± 11.11 years, respectively. There was no
difference in the distribution of gender between the 2
groups, with 10 males and 5 females in Group 1 and
9 males and 6 females in Group 2 (Table).
The mutagenicity of desflurane was evaluated
based on lymphocytes obtained from peripheral
blood in both groups, at the baseline and after 3 h
of anesthesia. The baseline SCE in Group 1 increased
from 6.48 ± 1.38 to 7.11 ± 1.55 SCE cell–1 after 3 h of
anesthesia (P > 0.05). The baseline SCE in Group 2
increased from 6.89 ± 1.81 to 8.19 ± 1.95 SCE cell–1
after 3 h of anesthesia (P < 0.05) (Figures 1 and 2).

Table. Data of the patients included in the study.
0.5 MAC
Male
Female
Age

1 MAC

10

9

5

6

41.06 ± 11.1

45.26 ± 11.7

6

4

2
N=

15

Group

15

15

1.00

15
2.00

Figure 1. The distribution of data in box plot graphics.
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7

SCE cell-1
Preoperative

After 3 h of anesthesia

6
5
4
3
2
1
0
0.5 MAC

Time

1 MAC

Figure 2. The pre- and postoperative mean SCE values of Groups
1 and 2.
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significant increase (P = 0.002). There are limited
studies related to the genotoxicity of desflurane in
the literature, though various studies have been
published regarding such effects of other anesthetic
gases. Szyfter et al. reported that sevoflurane had no
genotoxic effect in vivo or in vitro, and halothane
was reported to be more genotoxic than isoflurane
(17). Jaloszynski et al. showed that halothane and
isoflurane increased DNA damage (18). Karabıyık
et al. also indicated similarly high genotoxic effects
of both isoflurane and sevoflurane (11). Lüleci et al.
reported the mutagenic effect of sevoflurane on DNA
(9). In our study, we also found an increase in the SCE
frequencies after exposure to desflurane. Although
Lüleci et al. used sevoflurane both in the induction
and the maintenance of anesthesia, we only used
desflurane in the maintenance of anesthesia, as it was
not suitable for induction. We preferred thiopental
and fentanyl for the induction of anesthesia, as no
risk of genotoxic effects was reported previously (11).
Husum et al. reported that isoflurane exposure for a
short period did not have a mutagenic effect based
on the SCE frequencies (19). Akin et al. used 1 MAC
of desflurane in 15 female patients and found an
increase in SCE frequencies after both 1 and 2 h (12).
Our study revealed similar results at 1 MAC, and 0.5
MAC seemed relatively safer.
White et al. studied the SCE ratios after induction
with inhalation anesthetics. They indicated that
exposure to 1 MAC of halothane, enflurane,
isoflurane, methoxyflurane, and nitrogen protoxide
for 1 h did not change SCE frequencies, but exposure
to divinyl ether, fluroxene, and ethyl vinyl ether was

found to increase the SCE frequencies (3). Although
White et al. used inhalation anesthetics for 1 h, an
increase in SCE frequencies was reported to begin
after 1 h of exposure (9,11). We also did not use
nitrogen protoxide for induction, as teratogenic and
carcinogenic effects were reported (6,7). Bozkurt et
al. studied the SCE frequencies in operational staff
and indicated that there may not be a genotoxic
effect.(20). Hoerauf et al. studied the genotoxic
effects of inhalation anesthetics with SCE frequencies
and showed that nitrogen protoxide (11.8 ppm) and
isoflurane (0.5 ppm) increased the SCE frequencies
(5,21).
Bilban et al. reported an increase in the SCE
frequencies of operational staff after extended
exposure to anesthetic gases (22). Husum et al.
indicated that halothane and nitrogen protoxide did
not induce the SCE frequencies of the operational
staff exposed to anesthetic gases (23). In conclusion,
we showed the genotoxic effect after exposure to
desflurane at 1 MAC by studying the SCE frequencies.
It is very important to use lower doses of desflurane
or the less genotoxic inhalation anesthetics for
the safety of patients, particularly those with a
predisposition to genetic diseases or malignancy.
The potential risks for the operational staff exposed
to desflurane or other anesthetic gases also have to
be considered. It is also very important to determine
whether the genotoxicity of desflurane is reversible
over time or not. As there are limited reports related
to the genotoxicity of desflurane, it might be very
important to study its potential reversible effect.
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